Sridhar Epari
Overview
Explore the profile of Sridhar Epari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
628
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rajendra A, Sengar M, Korula A, Ganesan P, Jain H, K D, et al.
Blood Cancer J
. 2025 Mar;
15(1):38.
PMID: 40087298
Treatment of Burkitt Lymphoma/Leukemia (BL/L) in adults has evolved from the use of pediatric inspired regimens (CODOX-M/IVAC, hyper-CVAD, GMALL) to the use of lower intensity EPOCH regimens. The addition of...
2.
Shroff K, Shetty P, Singh V, Epari S, Sahay A, Moiyadi A
Clin Neurol Neurosurg
. 2025 Mar;
251:108838.
PMID: 40080942
Background And Introduction: Revision surgery for adult diffuse gliomas has benefits in terms of maximizing the extent of resection and providing accurate histopathological diagnosis. However, these benefits must be balanced...
3.
Dasgupta A, Sawant S, Chatterjee A, Gota V, Sahu A, Choudhari A, et al.
Cancer Med
. 2025 Mar;
14(5):e70657.
PMID: 40025673
Introduction: Chlorophyllin (CHL) effectively decreases the side effects of radiotherapy (RT) by scavenging radiation-induced free radicals and reactive oxygen species in preclinical trials. This study aims to assess the efficacy...
4.
Halder A, Jadhav P, Maitra A, Banerjee A, Hole A, Epari S, et al.
J Proteome Res
. 2025 Feb;
24(3):1180-1196.
PMID: 40000599
Meningioma, the most prevalent brain tumor, poses significant challenges due to its unclear transition from low-grade to aggressive forms, with limited knowledge about grade-specific markers. We have utilized vibrational spectroscopic...
5.
Schmid S, Mirchia K, Tietze A, Liu I, Siewert C, Nuckles J, et al.
Neuro Oncol
. 2024 Dec;
PMID: 39713960
Background: Intracerebral schwannomas are rare tumors resembling their peripheral nerve sheath counterparts but localized in the CNS. They are not classified as a separate tumor type in the 2021 WHO...
6.
Han J, Koh M, Boussi L, Sorial M, McCabe S, McCabe S, et al.
Blood Adv
. 2024 Oct;
9(3):583-602.
PMID: 39481087
Variances in global access to drugs and treatment practices make it challenging to understand the benefit of contemporary therapies in patients with relapsed and refractory (R/R) mature T-cell and natural...
7.
Rathi A, Choudhari A, Chatterjee A, Sahay A, Bhattacharya K, Sahu A, et al.
Int J Surg Pathol
. 2024 Oct;
:10668969241286243.
PMID: 39376094
Diffuse midline glioma, -altered is a rare and aggressive pediatric brain tumor with a grim prognosis. Diffuse midline glioma is characterized by specific molecular alterations, including mutations, and involves deep...
8.
Sahu A, Mathew R, Ashtekar R, Dasgupta A, Puranik A, Mahajan A, et al.
Front Nucl Med
. 2024 Oct;
3:1040998.
PMID: 39355021
Introduction: Conventional magnetic resonance imaging (MRI) has limitations in differentiating tumor recurrence (TR) from radionecrosis (RN) in high-grade gliomas (HGG), which can present with morphologically similar appearances. Multiparametric advanced MR...
9.
Vaidya T, Sahu A, Epari S, Shetty O, Gurav M, Sahay A, et al.
Neurol India
. 2024 Aug;
72(4):747-755.
PMID: 39216028
Objective: Sporadic optic chiasmatic-hypothalamic gliomas (OCHGs), though histologically low-grade tumors, manifest as aggressive neoplasms radiologically, leading to difficulty in diagnosis. Molecular alterations of the BRAF gene are detectable in a...
10.
Singh A, Patil J, Ghogale S, Deshpande N, Girase K, Shetye N, et al.
Cytometry B Clin Cytom
. 2024 Jul;
106(5):359-369.
PMID: 39031805
Multicolor flow cytometry (MFC) is crucial in detecting occult or minimal bone marrow (BM) involvement by non-Hodgkin lymphomas (NHL), which may not be detected using trephine biopsy or imaging studies....